Recent data reveals most common cancers in Hawaiʻi

University of Hawaiʻi at Mānoa
Contact:
Posted: Jun 9, 2020


Brenda Hernandez
Brenda Hernandez

The University of Hawaiʻi Cancer Center’s Hawaiʻi Tumor Registry released updated cancer statistics in Hawaiʻi Cancer at a Glance, 2012-2016, which includes data on cancer incidence and mortality in the state of Hawaiʻi. 

The report shows that breast cancer remains the most frequently diagnosed cancer among women, while prostate cancer is the most common cancer among men. Hawaiʻi’s liver and stomach cancer incidence and mortality rates are significantly higher than the U.S., and lung cancer continues to be the leading cause of cancer death in the state. 

Hawaiʻi is a diverse state in its geography, as well as in its demographics. In addition to having no ethnic majority, it has the highest proportion of individuals of mixed-race ethnicity in the U.S., with two of every 10 residents describing themselves as more than one race.

“Hawaiʻi Cancer at a Glance, 2012-2016, acknowledges this diversity, and examines variation in cancer incidence and mortality by county and across various racial and ethnic groups,” Hawaiʻi Tumor Registry Principal Investigator Brenda Hernandez said. “Disparities in cancer risk and outcomes across racial and ethnic groups may reflect genetic variation as well as differences in diet, tobacco and alcohol use, obesity and other lifestyle exposures.” 

Key ethnic differences were also observed. Lung cancer incidence is highest in Filipinos and Native Hawaiians. Thyroid cancer incidence is highest in Filipino women. Liver cancer incidence and mortality are highest in Native Hawaiian men, and whites (both men and women) have the highest rates of melanoma.

Annually, an average of 7,010 Hawaiʻi residents are newly diagnosed with invasive cancer and 2,347 individuals die of cancer. There are more than 62,000 cancer survivors in the state. 

The Hawaiʻi Tumor Registry is responsible for cancer surveillance in the state of Hawaiʻi. It is a funded registry of the National Cancer Institute (NCI) Surveillance Epidemiology and End Results (SEER) Program. The Hawaiʻi Tumor Registry collects confidential data on cancer diagnosis, treatment and outcomes. The data is used to track cancer trends in the state and nation. 

“Tracking the rate of new cancer cases and deaths is critically important for the UH Cancer Center’s research on cancer prevention, early detection, treatment and survivorship,” Hernandez said. Publications from NCI SEER registries, such as Hawaiʻi Cancer at a Glance, 2012-2016, serve as an important resource for cancer research and public health activities throughout the nation.

Updated national and statewide cancer statistics reflect a reporting delay between the time an individual is diagnosed with cancer and the case is reported to cancer registries in order to obtain complete clinical and pathologic information, as well as the first course of treatment.  

This project has been funded in whole or in part with Federal funds from the National Cancer Institute, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN261201800011I.

About the University of Hawaiʻi Cancer Center

The University of Hawaiʻi Cancer Center through its various activities, including scientific research and clinical trials, adds more than $54 million to the Oʻahu economy. It is one of only 71 research institutions designated by the National Cancer Institute. Affiliated with the University of Hawaiʻi at Mānoa, the Center is dedicated to eliminating cancer through research, education, patient care and community outreach with an emphasis on the unique ethnic, cultural, and environmental characteristics of Hawaiʻi and the Pacific.  Learn more at uhcancercenter.org. Like us on Facebook at facebook.com/UHCancerCenter. Follow us on Twitter @UHCancerCenter.